CHASE MCCLARD: Open Payments
NPI 1801415625 · MURRAY, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$178 in 9 payments from 9 companies in 2025. Trend: 2023 $809 · 2024 $501 · 2025 $178
Food & beverage: $178
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 1 | $30 |
| ABBVIE INC. | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Novo Nordisk Inc | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
| PFIZER INC. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| Amgen Inc. | 1 | $15 |
Products named: Dexcom G6 Transmitter, UBRELVY, CAPLYTA, TRELEGY ELLIPTA, Ozempic, LEQVIO, NURTEC ODT, VOQUEZNA.
Industry payments across KY — which companies pay providers there.
